Author

Beatrice Brown

Chloe Reichel is the Petrie-Flom Center’s Communications Manager. She serves as Editor-in-Chief of the Bill of Health blog and leads the Center’s broader communications efforts.

Bioethics

November 22, 2019

Teva to Resume Production of Critical Pediatric Oncology Drug: Too Little, Too Late

By Beatrice Brown In my last blog post, I reflected on the ethical issues relevant to a critical shortage of a widely used pediatric oncology drug, vincristine. The shortage occurred after one of two pharmaceutical…

Teva to Resume Production of Critical Pediatric Oncology Drug: Too Little, Too Late
Bioethics

October 25, 2019

Ethical Reflections on the Recent Critical Shortage of Pediatric Cancer Drug

By Beatrice Brown Recently, news broke that there is a critical shortage of vincristine, a drug that is integral for treating pediatric cancers. According to the Children’s Oncology Group, Pfizer communicated that they were experiencing…

Ethical Reflections on the Recent Critical Shortage of Pediatric Cancer Drug
Bioethics

October 16, 2019

Challenging the Contours of the “Undue Burden” Standard in June Medical Services v. Gee: A Slippery Slope?

By Beatrice Brown On October 4, the Supreme Court announced that it would hear June Medical Services v. Gee, in which a 2014 Louisiana law that requires abortion providers to have admitting privileges at a…

Challenging the Contours of the “Undue Burden” Standard in June Medical Services v. Gee: A Slippery Slope?
Bioethics

September 30, 2019

“An Act Improving Medical Decision Making:” An Argument in Favor of MA House Bill 3388 and Senate Bill 843

By Beatrice Brown On September 10, 2019, the Joint Committee on Judiciary at the Massachusetts State House heard testimony regarding House Bill 3388 and Senate Bill 843, “An Act Improving Medical Decision Making.” The Massachusetts…

“An Act Improving Medical Decision Making:” An Argument in Favor of MA House Bill 3388 and Senate Bill 843
Bioethics

September 13, 2019

Trump’s Title X Gag Rule: An Ethical Conundrum for Planned Parenthood

By Beatrice Brown On August 19, Planned Parenthood announced that they would be leaving the Title X family planning program due to the Trump Administration’s new prohibition that restricts those who receive Title X funds…

Trump’s Title X Gag Rule: An Ethical Conundrum for Planned Parenthood

Beatrice Brown

Teva to Resume Production of Critical Pediatric Oncology Drug: Too Little, Too Late

Teva to Resume Production of Critical Pediatric Oncology Drug: Too Little, Too Late

Ethical Reflections on the Recent Critical Shortage of Pediatric Cancer Drug

Ethical Reflections on the Recent Critical Shortage of Pediatric Cancer Drug

Challenging the Contours of the “Undue Burden” Standard in June Medical Services v. Gee: A Slippery Slope?

Challenging the Contours of the “Undue Burden” Standard in June Medical Services v. Gee: A Slippery Slope?

“An Act Improving Medical Decision Making:” An Argument in Favor of MA House Bill 3388 and Senate Bill 843

“An Act Improving Medical Decision Making:” An Argument in Favor of MA House Bill 3388 and Senate Bill 843

Trump’s Title X Gag Rule: An Ethical Conundrum for Planned Parenthood

Trump’s Title X Gag Rule: An Ethical Conundrum for Planned Parenthood